Financial Overview
Here you will find a summary of Eli Lilly and Company's latest financial information.
| Latest Earnings Release and 10-Q | Date Filed | Format | Size | |
|---|---|---|---|---|
| Fourth Quarter Financial Results |  |
N/A | ||
| Form 10-Q | Oct 30, 2009 | 
|
557.4 KB | |
| Latest Annual Report and 10-K | Date Filed | Format | Size | |
| Annual Report and Proxy Statement |
|
1.7 MB | ||
| Form 10-K | Feb 27, 2009 |
|
1.7 MB | |
| Latest Proxy Statement | Date Filed | Format | Size | |
| Proxy Statement (PRE 14A) | Feb 8, 2010 |
|
1.3 MB | |
| Share Related Items | |
|---|---|
| Market Cap. (Mil) $ | 39,963.000 |
| Shares Out (Mil) | 1,149.022 |
| Float (Mil) | 1,008.723 |
Enrollment for Electronic Document Delivery of Proxy and related materials for shareholders.
Share Related information provided by Reuters.Data as of Feb 8, 2010.
Mil=Millions
Stock Information
| NYSE:LLY
$34.78 + 0.26 |
Feb 8, 2010
4:00 PM ET |
Quotes delayed at least 20 minutes. Information provided by eSignal.
